Schonfeld Strategic Advisors LLC Entera Bio Ltd. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 671,758 shares of ENTX stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
671,758Holding current value
$1.24 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ENTX
# of Institutions
17Shares Held
5.31MCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL3.88MShares$7.14 Million4.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT402KShares$738,7930.11% of portfolio
-
Ubs Group Ag168KShares$308,4260.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny57.6KShares$105,9840.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA28.9KShares$53,0950.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $53M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...